Brochure
10 Sep 2025

Revolutionizing Enzymes for Diagnostic and Biopharma Industries

PDF 187 kB

At Novonesis, we specialize in creating novelrecombinant enzymes tailored to the requiredtechnical parameters, all at scalable prices

Content provided by our supplier

Novonesis

  • Country/Region:
    Denmark
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical

Other Content from Novonesis (1)

  • Brochure Embrace biosolutions today for a sustainable and competitive tomorrow

    From concept to commercialization, Novonesis recombinant enzymes for fine chemicals provide a renewable and cost-efficient alternative to replace chemicals, metals, and solvents to improve processes cost-effectively by use of sustainable alternatives to chemicals for better quality APIs and intermediates. Partner with us to drive innovation in Pharma, diagnostics, cell culture, peptides, and regenerative medicine.